News and Media stories

New Technique Allows Scientists to Monitor Cell Communication

Discovery by esteemed Mount Sinai researcher and UK colleagues advances cancer research.

Lunenfeld scientist awarded Kidney Foundation of Canada Medal for Research Excellence

Widely regarded as one of the most dynamic and innovative physician-scientists working in nephrology, Dr. Quaggin is committed to finding new methods to halt the progression of kidney disease.

Dr. Tony Pawson honoured as ‘nation builder of the decade’ by The Globe and Mail

Commenting on Dr. Pawson’s latest honour, Dr. Jim Woodgett, Director of the Lunenfeld, said that “he is the exemplar of what is possible in Canada and acts as a role model for the thousands of trainees and colleagues working to improve health.”

Leading biomedical journal names stem cell technology ‘method of the year’

Breakthrough by Dr. Andras Nagy included among innovative discoveries named in Nature Methods.

Amalgamated Transit Union contributes new funds to support Dr. John Roder’s research

The Amalgamated Transit Union (ATU) has donated $51,000 to support neurobiology research conducted by Senior Investigator Dr. John Roder.

Lunenfeld scientist awarded Excellence in Research Award from the Association of Professors of Obstetrics and Gynaecology

Dr. Lee Adamson, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, has been honoured with this past year’s Excellence in Research Award by the Association of Professors of Obstetrics and Gynaecology of Canada (APOG).

Dr. Daniel Durocher discovers new clue in the genetics of cancer

 

New lab space to advance discoveries at the Lunenfeld

 

The Lunenfeld celebrates 25 years of leading-edge science

This year, we are truly proud to celebrate the 25th anniversary of the Samuel Lunenfeld Research Institute. Our 25th year provides an ideal time to reflect on how far we’ve come, and to what new, fantastic heights our future will take us.

New study by Dr. Laurence Pelletier provides important clues into the mechanisms of cell division

The Samuel Lunenfeld Research Institute’s Dr. Laurence Pelletier, in collaboration with researchers in the European Mitocheck Consortium, has discovered new proteins essential for proper cell division.

Dr. Rayjean Hung featured in top journal’s list of ‘hot papers’

The April issue of The Scientist, a leading life sciences journal with an international readership, features the research of Dr. Rayjean Hung, Lunenfeld Principal Investigator and leading cancer epidemiologist.

Dr. Tony Pawson named honorary Doctor of Medicine at Sweden’s most famous institute

Dr. Tony Pawson, Distinguished Lunenfeld Investigator and Kyoto Prize Laureate, has been named a new honorary Doctor of Medicine by the Karolinska Institutet in Sweden.

Lunenfeld researchers receive new funding from the Ontario Ministry of Research and Innovation

Provincial support will help Lunenfeld researchers continue leading-edge research into cancer other human illnesses.

Science Rendezvous showcases Mount Sinai’s excellence in biomedical research

The third annual Science Rendezvous festival opened its doors on May 8 to a world of innovation and discovery. The festival was a free public display of science culture across the GTA, including Mount Sinai Hospital and its Samuel Lunenfeld Research Institute.

Mount Sinai Hospital’s Dr. Jeffrey Wrana receives prestigious Premier’s Summit Award

Dr. Jeffrey Wrana, Lunenfeld Senior Investigator and the Mary Janigan Research Chair in Molecular Cancer Therapeutics, was honoured on May 18 at an awards ceremony held at the Metro Toronto Convention Centre.

Inaugural Canada Excellence Research Chair to join Mount Sinai Hospital

Dr. Frederick Roth brings his expertise in computational genomics to the Lunenfeld’s Systems Biology group next year.

Mount Sinai Hospital team identifies first global ‘road map’ of important protein interactions implicated in cell signalling

A team of scientists at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, as well as colleagues in Scotland and the United States, have generated a comprehensive road map of the signalling proteins that control many aspects of cellular behaviour in yeast cells.

Anne Claude Gingras copy intranet.jpg

 

Anne Claude Gingras copy.jpg

 

Jeff Wrana copy.jpg

 

Jeff Wrana copy intranet.jpg

 

Anne Claude Gingras copy internet.jpg

 

Jeff Wrana copy intranet.jpg

 

wrana PSA event.copy.internet.jpg

 

wrana psa.jpg

 

Mount Sinai Hospital cancer researcher named one of Canada’s Top 40 Under 40

Dr. Daniel Durocher, Lunenfeld Senior Investigator and the Thomas Kierans Research Chair in Mechanisms of Cancer Development, has been named one of Canada’s Top 40 Under 40, an award presented annually to young leaders of today and tomorrow. The award is in recognition of Dr. Durocher’s tremendous research accomplishments, and his impact on Canada’s biomedical community.

Dan Durocher copy internet.jpg

 

A ‘Splice’ of Real Science

George Charames: Lunenfeld molecular oncologist trainee, and Scientific Consultant for new biotech thriller.

IMG_1936 copy.jpg

 

Low dose combination therapy for the prevention of type 2 diabetes

In a pioneering study, researchers including Lunenfeld Senior Investigator Dr. Bernie Zinman have shown that use of low-dose combination therapy reduces the risk of progression to type 2 diabetes by two thirds, in people at risk of developing the disease.

Zinman portrait 2009 copy.jpg

 

Zinman portrait 2009 copy.jpg

 

Dr. Tony Pawson named honorary Doctor of Science at McMaster University

Dr. Tony Pawson, Distinguished Investigator at the Lunenfeld and Kyoto Prize Laureate, has been named an honorary Doctor of Science by McMaster University in Hamilton.

Pawson copy.jpg

 

L_Siminovitch copy.jpg

 

The Lunenfeld: 25 Years of Research Breakthroughs

The Samuel Lunenfeld Research Institute celebrates its 25th anniversary on July 1. From extraordinary discoveries in cancer research, to leading-edge breakthroughs in stem cell biology, Lunenfeld experts are taking steps daily to improve the health of Canadians. Read on for an overview of our research breakthroughs since the Institute’s early days!

Dennis copy.jpg

 

Lunenfeld PhD student to begin prestigious fellowship at Harvard University

John Calarco, a PhD candidate co-supervised by Drs. Mei Zhen and Ben Blencowe, has received an exciting three-year research fellowship to Harvard University’s Center for Systems Biology, as part of the university’s Bauer Fellows program.

Building better joint replacements: Mount Sinai Hospital researchers receive new grant from the U.S. Army

Funding support will help Lunenfeld scientists continue leading-edge research into joint replacements and regenerative medicine.

Calarco_image copy.jpg

 

Congratulations to the Lunenfeld on 25 years of leading-edge research!

This year, Canada Day also marked the 25th anniversary of the Samuel Lunenfeld Research Institute of Mount Sinai Hospital—one of the world’s leading centres in biomedical research. Since 1985, Lunenfeld experts have helped put Canadian science on the global map of discovery and innovation.

K_Siminovitch copy.jpg

 

Lunenfeld researchers’ discovery could lead to new treatments for cancer and other illnesses

The Samuel Lunenfeld Research Institute’s Drs. Frank Sicheri and Mike Tyers, in collaboration with researchers at the University of Edinburgh and McMaster University, have discovered a previously unknown small molecule that inhibits a key enzyme involved in several important cellular processes.

Frank Sicheri copy.jpg

 

Frank Sicheri copy.jpg

 

Mount Sinai Hospital scientists uncover important clues in the biology of stem cells

Discovery will advance stem cell technologies worldwide and promote the development of new regenerative medicines...

Andras Nagy copy.jpg

 

Mount Sinai Hospital scientists receive new funding from the Canadian Institutes of Health Research

Federal support will help Lunenfeld researchers continue leading-edge research into cancer and other human illnesses...

Lunenfeld researcher receives the Lloyd S.D. Fogler Award of Excellence

Dr. Helen McNeill, a Senior Investigator at the Samuel Lunenfeld Research Institute, was awarded the Lloyd S.D. Fogler (QC) Award of Excellence for her pivotal research in cancer biology.

HelenMcNeill copy intranet.jpg

 

Mount Sinai Hospital researcher discovers additional clues in the genetics of liver disease

Findings will lead to personalized treatment options for primary biliary cirrhosis, as well as other autoimmune diseases.

Kathy Siminovitch copy.jpg

 

Acclaimed Mount Sinai Hospital researcher elected into the Royal Society of Canada

Dr. John Roder recognized for outstanding achievements in neuroscience...

John Roder copy internet.jpg